SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending as investors discuss its potential inclusion in the S&P 500, with the official announcement expected soon. The community is weighing the potential for a short squeeze against the historical trend of stocks dropping after being added to the index. Optimistic traders believe the inclusion, along with upcoming events, will drive the stock higher.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as it joins the S&P 500, sparking excitement and debate about potential short squeezes and future price movement. The community is discussing whether the stock was pumped prior to the announcement and speculating on profit-taking strategies. Some investors express frustration for selling earlier, while others are optimistic about long-term growth.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to its low float, with traders speculating it could be the next stock to experience a significant squeeze. The community is actively discussing its potential for a rapid price increase, drawing comparisons to other low-float stocks that have recently made substantial moves. A recent land sale boosting NAV is also circulating.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is trending as traders discuss the implications of its new ticker symbol and potential connections to blockchain technology through Tzero, drawing comparisons to past meme stock surges like $GME. The community is actively debating whether this is a fresh start or another fleeting rally, and speculating about possible involvement from figures like Ryan Cohen. Some investors believe Overstock's transition to Bed Bath & Beyond, combined with blockchain assets, could drive a significant turnaround.

Pineapple Financial, Inc. is a Canadian based mortgage technology and brokerage company, which engages in the mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. The company also provides back-office services, together with pre-underwriting support services. The company was founded by Shubha Dasgupta, Kendall Marin, and Charles Andrew Green on October 16, 2015 and is headquartered in North York, Canada.

Pineapple Financial Inc

Pineapple Financial ($PAPL) is trending due to a recently closed $100M private placement and a move into Injective (INJ) tokens, sparking high volatility. The community is buzzing about potential short squeezes and halts, with bulls anticipating further upside and bears cautioning about dilution. Traders are closely watching price action and momentum, with some eyeing new entries while others secure profits.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending due to discussions surrounding a report linking Tylenol use during pregnancy to autism, sparking community debate about the validity and potential market impact. Some investors view the dip as a buying opportunity, dismissing the report, while others express concern over potential lawsuits and long-term effects on the company. The broader context includes Kenvue's position as a consumer health company and its relationship with Johnson & Johnson.

K9 Finance, a Shibarium-based LSD platform, offers core DeFi services and acts as an official validator. Rewarding $KNINE holders with $BONE for block validation, it aims to drive DeFi adoption via the 'Roundtable of Dogs' DAO, which governs treasury and roadmap decisions.

K9 Finance DAO

K9 Finance DAO ($KNINE.X) is trending as the project continues to build on Shibarium, with the community actively discussing staking $BONE for $knBONE and earning rewards through yield farming. The launch of Bonecrusher v3 and the ongoing retro airdrop are also key catalysts driving interest in the project. K9 Finance aims to enhance DeFi within the Shiba Inu ecosystem, focusing on liquid staking and DAO governance.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as the community rallies around the token's $SOL.X reward system for holders, emphasizing its potential for passive income. Despite some volatility and past challenges, the community highlights its resilience and the arrival of new developers, sparking renewed optimism. Discussions also focus on upcoming events and partnerships, contributing to the token's visibility.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma is trending as investors discuss the potential implications of recent inducement grants and upcoming Phase 3 data, with some speculating about the company's confidence in positive results based on hiring activity. Community perspectives are divided, with bullish arguments emphasizing the potential for a successful outcome and high price targets, while bearish viewpoints focus on past trial data and concerns about short selling strategies. The stock's high short interest and upcoming data readout are contributing to increased volatility and active conversation.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is trending as investors discuss its potential for recovery amid S&P 500 removal and debates around solar tax credits. Community talking points include the stock's downtrend, possible bottoming, and sensitivity to interest rate cuts, while some express concerns over policy and market conditions. Despite mixed sentiment, there's optimism about Enphase's technology and long-term prospects in the solar energy sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sai Life Sciences’ stock fell more than 5% on Tuesday on reports of private equity major TPG Asia selling its entire 15.2% stake in the company.According to CNBC-TV18, TPG Asia offloaded its stake via a block deal valued at around ₹2,810 crore. The PE firm reportedly sold around 3.16 crore shares at a floor price of ₹874 per share, representing a discount of about 3.5% to the last closing price of ₹906.At the time of writing, <a href="https://stocktwits.com/symbol/SAILIFE.NSE">Sai Life Sciences shares</a> were down 4.85% at ₹862.Trend Remains BullishDespite the decline on Tuesday, the broader trend remains bullish as long as Sai Life Sciences’ stock holds above ₹801, said SEBI-registered <a href="https://stocktwits.com/Wealthwise_research">analyst Manish Kushwaha</a>.The stock continues to respect its upward trendline, which has been tested multiple times and is proving to be a strong dynamic support, he added. Recently, the price touched the ₹900 mark but faced selling pressure, retracing to around ₹863.<stembedurl>https://stocktwits.com/Wealthwise_research/message/626526873</stembedurl>For now, the analyst flagged the ₹850 - ₹860 levels as the stock’s critical zone. Sustaining above this range could keep the uptrend intact, opening the possibility of a retest of the ₹900 - ₹910 range.A successful breakout from this region may even drive the stock toward the next psychological level at ₹950 and beyond, he added.On the&nbsp;other hand, a breakdown below ₹801 with strong volumes would signal weakness, potentially triggering a correction toward the ₹720-₹750 range.Retail sentiment slid to ‘extremely bearish’ on Stocktwits. It was ‘neutral’ a day ago.<figure class="image"><img style="aspect-ratio:850/82;" src="https://news.stocktwits-cdn.com/sai_life_png_9edd45b206.webp" alt="sai life.png" width="850" height="82"><figcaption>Sai Life Sciences Sentiment Meter and Message Volumes at 01:45 p.m. IST on August 26 | Source: Stocktwits</figcaption></figure>The drug CRDM company has seen its stock grow nearly 15% in value so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a chart depicting stock market crash, is displayed on a mobile phone screen in Ankara, Turkiye on August 5, 2024. (Photo by Osmancan Gurdogan/Anadolu via Getty Images)

Sai Life Sciences Slips On PE Exit; SEBI RA Remains Bullish, Sees 10% Potential Upside

TPG Asia reportedly sold its entire 15.2% stake at a discounted floor price

Equity

Indian equity markets closed higher on Monday, led by strong buying in IT stocks after U.S. Federal Reserve Chair Jerome Powell’s dovish remarks raised expectations of a possible interest rate cut next month. It marked the benchmark indices’ seventh gain in eight sessions. Most indices closed in the green, barring PSU Banks, media, and FMCG.The broader markets are likely to open flat to negative on Tuesday, with the GIFT Nifty, an early indicator for the Nifty 50 index, down 0.07% to 24,917.5 at 8:30 a.m. IST.The truncated week will be crucial for Indian equities as the 50% tariffs imposed by US President Donald Trump on Indian goods come into effect from August 27. Investors will also closely monitor developments in India’s relations with China and Russia ahead of the Shanghai Cooperation Organisation (SCO) summit later this month.Stock WatchSai Life Sciences: TPG Asia VII SF is planning to exit Sai Life Sciences by selling its entire 14.72% stake via block deals worth about ₹2,500 crore at a floor price of ₹860 per share, according to CNBC-TV18.One 97 Communications (Paytm): Paytm’s Board has approved ₹455 crore in fresh investments across subsidiaries, alongside a group-level restructuring to streamline operations. It also cleared share transfers, making Foster Payment a wholly owned subsidiary and shifting a 55% stake in First Games Technology to Paytm Services.UCO Bank, Central Bank of India, Punjab &amp; Sind Bank, Indian Overseas Bank: The government has appointed Goldman Sachs as the sole banker to oversee stake sales in these four PSU banks, CNBC-TV18 reported.HDFC Bank: To begin trading adjusted for their bonus share issue.Aditya Birla Capital: RBI has approved the appointment of Vishakha Mulye as MD &amp; CEO for five years and Rakesh Singh as Executive Director &amp; CEO (NBFC) until July 2027.Protean eGov Technologies: The company secured a ₹1,160 crore work order from UIDAI to operate district-level Aadhaar Seva Kendras.Navin Fluorine International: CEO of CDMO Business, Rajendra Sahu, has resigned effective Sept. 20, 2025, and Vijay Kaiwar will take over as CEO from Sept. 21, 2025.3M India: The Board has appointed Aseem Joshi as President and Managing Director (Designate), effective Oct. 13, 2025.Jammu &amp; Kashmir Bank: The Board approved Sankarasubramanian Krishnan as Non-Executive Part-Time Chairman until March 2028, subject to RBI approval.Tata Motors: NCLT Mumbai has approved the Composite Scheme of Arrangement between Tata Motors, TML Commercial Vehicles, and Tata Motors Passenger Vehicles.Great Eastern Shipping Company: The firm will add two secondhand vessels — a Suezmax crude carrier and a Kamsarmax dry bulk carrier — by Q3 FY26, increasing its fleet size to 40 ships.Lemon Tree Hotels: The company has signed a license agreement for a new Keys Select hotel in Nasik, to be managed by Carnation Hotels.Suraj Estate Developers: Suraj Estate acquired a 644 sq. m. land parcel in Lower Parel, Mumbai, to merge with an ongoing project, creating a 1,310 sq. m. consolidated site with a GDV of ₹130 crore.Tamil Nadu Newsprint and Papers: LIC sold 4 lakh shares (0.58% equity) in the company at ₹171 apiece, trimming its stake to 1.8% as of June 2025.Capital Infra Trust: CIM Investment Fund ICAV bought 29.2 lakh units (1.06% stake) in Capital Infra Trust at ₹79.45 per unit.Earnings TodaySri Lotus Developers and Realty, Punjab Communications, and KDJ Holidayscapes and Resorts.Mainboard ListingVikram Solar, Patel Retail, Gem Aromatics, and Shreeji Shipping GlobalIPOs To Open TodayVikran Engineering and Anlon HealthcareFor updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Trading Radar For August 26: HDFC Bank, Paytm, Protean eGov Technologies, Sai Life Sciences Stocks On Investors’ Watchlist

Indian equity markets closed higher on Monday, led by strong buying in IT stocks after U.S. Federal Reserve Chair Jerome Powell’s dovish remarks raised expectations of a possible interest rate cut next month.

HDFC Bank, Paytm, Protean eGov Technologies, Sai Life Sciences Stocks On Investors’ Watchlist

Vikram Solar and Patel Retail are set to make their market debut today

Indian equity markets remain stuck in a tight range as a lack of directional triggers keeps the sentiment subdued. But SEBI-registered analysts have flagged a few stocks with breakout potential ahead.&nbsp;Let’s take a look at their stock recommendations:&nbsp;Sai Life Sciences&nbsp;Analyst&nbsp;<a href="https://stocktwits.com/Financewithpalak">Palak Jain</a> has flagged&nbsp;<a href="https://stocktwits.com/symbol/SAILIFE.NSE">Sai Life Sciences</a> as the stock has broken out above a significant resistance level, indicating a potential upward trend.Its technical chart shows a channel formation, suggesting a potential continuation of the uptrend. And the surging trading volumes support the breakout and indicate a strong investor interest in the stock.<stembedurl>https://stocktwits.com/Financewithpalak/message/624710438</stembedurl>Analyst&nbsp;<a href="https://stocktwits.com/Japfinserve">Varunkumar Patel</a> too shared a buy call on Sai Life. He recommended entering at ₹895-₹900, with a stop loss of ₹795 for a target price of ₹1,049 over a one-month timeframe.<stembedurl>https://stocktwits.com/Japfinserve/message/624711221</stembedurl>Alpex Solar&nbsp;Jain’s second pick is&nbsp;<a href="https://stocktwits.com/symbol/ALPEXSOLAR.NSE">Alpex Solar</a> as technicals suggest potential for further gains. She recommended buying with a target price of ₹1,400-₹1,450, and a stop loss of ₹1,275.&nbsp;The stock has seen a decisive breakout above a significant resistance level, accompanied by a good volume buildup, indicating a potential upward trend.She believes that the company's growth prospects in the solar energy sector, driven by increasing demand for renewable energy sources, could be a key driver of its stock performance.<stembedurl>https://stocktwits.com/Financewithpalak/message/624710505</stembedurl>Indian BankAnd analyst&nbsp;<a href="https://stocktwits.com/Vinaytaparia">Vinay Taparia</a> flagged a breakout in&nbsp;<a href="https://stocktwits.com/symbol/INDIANB.NSE">Indian Bank</a>, with the stock trading at an all-time high. Its Relative Strength Index (RSI) stands near 70.&nbsp;He predicts an upside till ₹750 in the short term, but a close below ₹640 negates this view.<stembedurl>https://stocktwits.com/Vinaytaparia/message/624709772</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Indian Markets Rangebound, But SEBI Analysts Flag 3 Stocks With Bullish Technical Signals

Analysts see fresh upside potential in Sai Life Sciences, Alpex Solar, and Indian Bank.

As we head into a fresh month, three SEBI-registered analysts have shared their outlook on their top technical picks for August.&nbsp;While Sai Life and Coromandel are seeing strong institutional buying and breakout momentum, Mazagon Dock faces resistance and profit booking, prompting a more selective approach.Let’s take a look at their recommendations for August:&nbsp;Sai Life SciencesSEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Finlight_Research">Finlight Research</a> noted that the stock is continuing a bullish trend, breaking out of a major consolidation range. It is trading well above key resistance-turned-support (₹800) and has hit fresh record highs recently, fueled by strong buying momentum.This rally is supported by strong volumes, confirming the buying interest of institutions. Additionally,&nbsp;<a href="https://stocktwits.com/symbol/SAILIFE.NSE">Sai Life stock</a> trades above all major moving averages and its Relative Strength Index (RSI) is neither overbought or oversold, suggesting strength.&nbsp;They recommend buying on dips toward moving averages or retesting the support level (near ₹800), for targets of ₹875, ₹900, ₹950 and above with a stop loss of ₹775 on a weekly closing basis.<stembedurl>https://stocktwits.com/Finlight_Research/message/622982745</stembedurl>Sai Life shares have risen 7% year-to-date (YTD).Coromandel&nbsp;Analyst&nbsp;<a href="https://stocktwits.com/BHARATSHARMA_StockAce_RA">Bharat Sharma of Stockace Financial Services</a>&nbsp;has identified a swing cum positional breakout opportunity in&nbsp;<a href="https://stocktwits.com/symbol/COROMANDEL.NSE">Coromandel</a>. He noted that the stock prices have surpassed the previous peaks' resistance, accompanied by increased volume &amp; large green candle, indicating upside momentum.He recommends buying it between the&nbsp;₹2,550-₹2,610 range to ride on further gains for a target price of&nbsp;₹2,800, ₹3,000, and higher with a stop loss at ₹2,450-₹2,400 on a closing basis for a timeframe of 30 to 60 days.<stembedurl>https://stocktwits.com/BHARATSHARMA_StockAce_RA/message/622981983</stembedurl>Coromandel shares have risen 35% year-to-date (YTD).Mazagon Dock&nbsp;And analyst&nbsp;<a href="https://stocktwits.com/HarikaEnjamuri_SEBI_RA">Harika Enjamuri</a> identified&nbsp;<a href="https://stocktwits.com/symbol/MAZDOCK.NSE">Mazagon Dock</a> as the stock to watch in August. While it has demonstrated consistent performance within the defence and shipbuilding sectors, supported by a robust order book, healthy cash flows, and a near-monopolistic market position, recent quarterly trends indicate a moderation in operating momentum that warrants a more selective and tactical investment approach.She noted that the stock traded at 50x P/E, 13.8x P/B, and EV/EBITDA over 30x, which suggests a limited valuation comfort based on current earnings trajectory. Additionally, the stock is in a corrective phase, having breached the 9-day and 100-day moving averages (₹2,874 and ₹2,977), indicating short-term weakness.Enjamuri sees support at ₹2,650 and adds that a breakdown could extend downside to ₹2,444. On the weekly chart, the long-term uptrend remains intact, though profit booking from the ₹3,370 peak continues. A sustained close above ₹2,975 would be required to re-establish bullish momentum.She recommends entering at ₹2,580–₹2,650 with a target of ₹3,250 (indicating 25–28% upside) for a stop loss at ₹2,380. Suggested time frame for this strategy is four to eight weeks (swing to medium-term).<stembedurl>https://stocktwits.com/HarikaEnjamuri_SEBI_RA/message/622983195</stembedurl>Mazagon shares have risen 24% year-to-date (YTD).Stocktwits’ Yash Upadhyay breaks down these stocks to watch in August! Watch&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=kqRXOJm7Szg">here</a> to discover analysis and views from SEBI-registered advisors.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

August Stock Watch: Here’s Why Sai Life, Coromandel, Mazagon Are On Analysts’ Radar

While Sai Life and Coromandel are seeing strong institutional buying and breakout momentum, Mazagon Dock faces resistance and profit booking, prompting a more selective approach.

Here’s Why Sai Life, Coromandel, Mazagon Are On Analysts’ Radar

Analysts highlight technical setups in three stocks, citing breakout, volume surge and other bullish indicators. 


Sai Life Sciences is attracting investor attention with a major breakout on the charts and robust underlying fundamentals. The stock is currently trading at ₹847.35, after hitting an all-time high of ₹852.6 earlier on Wednesday.Technically, the stock has recently broken out of a long consolidation zone, now trading above the ₹800 resistance-turned-support level, backed by strong volumes, noted SEBI-registered firm <a href="https://stocktwits.com/Finlight_Research">Finlight Research India</a>.&nbsp;&nbsp;<stembedurl>https://stocktwits.com/Finlight_Research/message/622982745</stembedurl>The price remains well above the key 20-day, 50-day, and 200-day simple moving averages (SMA). The relative strength index (RSI) is at around 68, reflecting continued strength without being in overbought territory. At the same time, the moving average convergence/divergence (MACD) remains positive with no signs of a bearish crossover.Sai Life operates across drug discovery, preclinical services, process development, and commercial manufacturing. The company services over 280 global pharma and biotech firms, including 18 of the top 25 pharma giants worldwide.Fundamentally, its revenue mix is diversified, with 43% of total revenue coming from early-stage drug discovery, and the remainder from contract development and manufacturing, Finlight Research said in a post.With 97% of revenues from exports, the company enjoys insulation from domestic disruptions but remains exposed to currency fluctuations and global regulatory risks.For traders, the <a href="https://stocktwits.com/symbol/SAILIFE.NSE">stock</a> remains a strong “buy on dips” candidate, the analyst said. Buying near the ₹800 retest level could offer favorable risk-reward with targets of ₹875, ₹900, and ₹950+ while a stop-loss can be placed at ₹775.Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes.<figure class="image"><img style="aspect-ratio:924/82;" src="https://news.stocktwits-cdn.com/Sai_Life_png_496951d1da.webp" alt="Sai Life.png" width="924" height="82"><figcaption>Sai Life Sciences' Sentiment Meter and Message Volumes at 03:42 p.m. IST on July 30 | Source: Stocktwits</figcaption></figure>Year-to-date, the stock has gained around 13%For updates and corrections, email newsroom[at]stocktwits[dot]com

Pharma stock. (Photo credit: Getty Images)

Sai Life Sciences Hits Record High; SEBI RA Finlight Research Sees Upside Potential Above ₹950

The analyst recommends a ‘buy on dips’ strategy at ₹800, citing export-led growth and strong fundamentals.

The charts of several mid and small-cap stocks are flashing bullish signals this week, and traders are on the lookout for possible breakout opportunities.According to SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/billiondreamz">Rohit Mehta</a>, five stocks emerged as breakout candidates based on their price action, volume patterns, and immediate resistance levels.<stembedurl>https://stocktwits.com/billiondreamz/message/619677338</stembedurl>His calls highlight setups supported by classical chart formations, such as the Cup &amp; Handle, and long-term trendline breaks.Jeena Sikho Lifecare&nbsp;<a href="https://stocktwits.com/symbol/JSLL.NSE">Jeena Sikho Lifecare</a> is testing its supply zone near ₹500 with a Cup &amp; Handle pattern forming on the daily chart.&nbsp;Mehta noted a strong price recovery and volume surge, adding that a breakout above ₹500 could confirm upside momentum.SML Isuzu<a href="https://stocktwits.com/symbol/SMLISUZU.NSE">SML Isuzu</a> has already cleared resistance near ₹2,000, accompanied by a sharp volume spike. Mehta said sustaining above ₹2,100 may unlock further upside potential.Innovana<a href="https://stocktwits.com/symbol/INNOVANA.NSE">Innovana</a> has broken above the ₹525–₹540 supply zone after consolidating for months.&nbsp;Mehta described the move as a clean breakout and flagged the ₹540–₹560 range as a potential retest entry.CESC<a href="https://stocktwits.com/symbol/CESC.NSE">CESC</a> broke out of a long-term falling trendline and the ₹170–₹172 resistance zone.&nbsp;Mehta said the price action resembles a Cup pattern and advised watching the zone closely for a possible retest entry.Sai Life Sciences<a href="https://stocktwits.com/symbol/SAILIFE.NSE">Sai Life Sciences</a> moved out of a prolonged consolidation phase with a breakout above ₹785.&nbsp;Mehta said the former resistance could now act as support and pointed to strong volume as confirmation of the move.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Five Breakout Stocks To Watch: SEBI RA Rohit Mehta Sees A Potential Rally This Week

Several mid and small-cap names are drawing fresh interest from traders this week amid bullish setups and strong volume cues. 

Sai Life Sciences Ltd. operates as a contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities to global pharmaceutical companies and biotechnology firms. The company was founded on January 25, 1999 and is headquartered in Hyderabad, India.

SAILIFE.NSE
Sai Life Sciences Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest SAILIFE.NSE News

SAILIFE.NSE Sai Life Sciences Ltd.